๐Ÿ˜ตabnormal psychology review

Long-acting injectable antipsychotics

Written by the Fiveable Content Team โ€ข Last updated August 2025
Written by the Fiveable Content Team โ€ข Last updated August 2025

Definition

Long-acting injectable antipsychotics are medications used to treat schizophrenia and other psychiatric disorders, administered through injection, which provide therapeutic effects over an extended period, typically weeks to months. This method of delivery helps improve adherence to treatment, reduces the risk of relapse, and enhances overall management of symptoms by ensuring a more consistent level of medication in the bloodstream compared to oral forms.

5 Must Know Facts For Your Next Test

  1. Long-acting injectable antipsychotics are typically administered every two to four weeks, depending on the specific medication and individual needs.
  2. These medications help prevent relapse in patients with schizophrenia by maintaining stable drug levels in the body.
  3. They can be especially beneficial for individuals who have difficulty remembering to take daily oral medications, thereby improving treatment adherence.
  4. Common long-acting injectable antipsychotics include depot formulations of medications like risperidone, paliperidone, and aripiprazole.
  5. Side effects can vary but may include weight gain, sedation, and injection site reactions, so monitoring is essential during treatment.

Review Questions

  • How do long-acting injectable antipsychotics improve treatment adherence among patients with schizophrenia?
    • Long-acting injectable antipsychotics enhance treatment adherence by reducing the frequency of medication administration compared to daily oral doses. Patients receive these injections every two to four weeks, which alleviates the burden of daily pill-taking. This method also minimizes the risk of missed doses, leading to a more consistent medication level in the body and better management of schizophrenia symptoms.
  • Discuss the potential advantages and disadvantages of using long-acting injectable antipsychotics compared to oral antipsychotic medications.
    • The advantages of long-acting injectable antipsychotics include improved adherence due to less frequent dosing and a reduced risk of relapse among patients. However, disadvantages can involve potential side effects such as injection site reactions or discomfort from needles. Additionally, the infrequent administration means that any adverse effects may take longer to resolve compared to oral medications where doses can be adjusted more quickly.
  • Evaluate the impact of long-acting injectable antipsychotics on the overall management of schizophrenia and their role in reducing hospitalizations.
    • Long-acting injectable antipsychotics significantly impact the management of schizophrenia by promoting stable therapeutic drug levels and reducing symptom exacerbations that lead to hospitalization. Their ability to enhance adherence helps maintain consistent treatment outcomes, leading to fewer relapses and hospital admissions. This not only improves the quality of life for patients but also decreases healthcare costs associated with repeated emergency interventions and long-term care.
2,589 studying โ†’